Study selection Studies were selected using the PICO (patient/population, intervention, comparison and outcomes) format to include those that studied patients with DM2 (Population), comparing those on one of GLP-1 Ras: Dulaglutide (Trulicity), Exenatide extended release (Bydureon), Exenatide (Byetta), Semaglutide (Ozempic), Semaglutide (Rybelsus), Liraglutide (Victoza), or Lixisenatide (Adlyxin) (Intervention) to patients not on GLP-1 RAs (Comparison), and assessing for all-cause mortality, cardiovascular mortality, and composite endpoint of ventricular and atrial arrhythmias and sudden cardiac death (Outcomes)
Summary Ozempic Alternatives Although Ozempic isn 't licensed for weight loss, other weight loss injections are licensed in the UK
Both offer unique benefits, but choosing the right one can impact your experience with the medication
doi:10.1677/JOE-06-0148 215
Cassia cinnamon, commonly used in glucose-management trials, contains coumarin, which may damage the liver in high doses
Ongoing studies continue to explore these relationships across multiple areas of metabolic research